A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
Condition(s):Post-Menopausal OsteoporosisLast Updated:June 17, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Post-Menopausal OsteoporosisLast Updated:June 17, 2011Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:January 11, 2011Completed
Condition(s):Furcation DefectsLast Updated:November 20, 2015Completed
Condition(s):OsteoporosisLast Updated:March 12, 2009Completed
Condition(s):Nonalcoholic Fatty Liver; Osteoporosis, PostmenopausalLast Updated:July 28, 2023Recruiting
Condition(s):Osteoporosis, PostmenopausalLast Updated:February 3, 2022Completed
Condition(s):HIV InfectionsLast Updated:August 7, 2009Completed
Condition(s):OsteoporosisLast Updated:August 4, 2008Unknown status
Condition(s):OsteoporosisLast Updated:March 26, 2019Completed
Condition(s):Hyperparathyroidism, Primary; OsteoporosisLast Updated:April 15, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.